These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8146266)

  • 1. [Epidemiologic findings on the spontaneous long-term course of psychogenic disease over 10 years].
    Franz M; Schepank H; Reister G; Schellberg D
    Psychother Psychosom Med Psychol; 1994 Jan; 44(1):22-8. PubMed ID: 8146266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence and follow-up characteristics of neurologically relevant psychogenic symptoms].
    Franz M; Schellberg D; Reister G; Schepank H
    Nervenarzt; 1993 Jun; 64(6):369-76. PubMed ID: 8332229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indicators and factors of influence on the long-term follow-up of psychogenic diseases--a comparison of extreme groups].
    Franz M; Schellberg D; Schepank H
    Psychother Psychosom Med Psychol; 1995 Feb; 45(2):41-51. PubMed ID: 7892433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiologic findings of the etiology of psychogenic diseases].
    Franz M; Schellberg D; Schepank H
    Z Psychosom Med Psychoanal; 1993; 39(4):375-86. PubMed ID: 8273431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].
    Franz M; Schepank H
    Z Arztl Fortbild Qualitatssich; 1997 Dec; 91(8):723-7. PubMed ID: 9487623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different lay etiologic attributions of psychogenically ill probrands from an epidemiologic field study].
    Thebaldi B; Franz M; Schellberg D; Schepank H
    Z Psychosom Med Psychoanal; 1996; 42(1):71-87. PubMed ID: 8852797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Participation refusal by probands in an epidemiologic long-term study--sociodemographic, clinical and psychometric findings].
    Franz M; Schepank H; Wirth T; Schellberg D
    Psychother Psychosom Med Psychol; 1992 Nov; 42(11):392-9. PubMed ID: 1494615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The 4-week prevalence of somatoform disorders and associated psychosocial impairment].
    Schoepf D; Heun R; Weiffenbach O; Herrmann S; Maier W
    Nervenarzt; 2003 Mar; 74(3):245-51. PubMed ID: 12627239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade of spontaneous long-term course of psychogenic impairment in a community population sample.
    Franz M; Lieberz K; Schmitz N; Schepank H
    Soc Psychiatry Psychiatr Epidemiol; 1999 Dec; 34(12):651-6. PubMed ID: 10703275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study.
    Feinstein A; Stergiopoulos V; Fine J; Lang AE
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(3):169-76. PubMed ID: 11513100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis and spontaneous follow-up of psychological health and psychogenic disease].
    Schepank H
    Z Psychosom Med Psychoanal; 1991; 37(4):375-88. PubMed ID: 1767602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inadequate utilization of somato-medical services by psychogenically ill patients].
    Franz M; Schepank H
    Fortschr Neurol Psychiatr; 1994 Feb; 62(2):40-5. PubMed ID: 8150407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting extreme patterns of long-term course of psychogenic impairment: a ten-year follow-up.
    Franz M; Tress W; Schepank H
    Soc Psychiatry Psychiatr Epidemiol; 1998 Jun; 33(6):243-51. PubMed ID: 9640091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Mannheim Cohort Project--prevalence of psychogenic diseases in cities].
    Schepank H; Hilpert H; Hönmann H; Janta B; Parekh H; Riedel P; Schiessl N; Stork H; Tress W; Weinhold-Metzner M
    Z Psychosom Med Psychoanal; 1984; 30(1):43-61. PubMed ID: 6608195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic indicators of psychogenic diseases in adulthood based on childhood variables].
    Reister G; Franz M; Wacker A
    Z Psychosom Med Psychoanal; 1993; 39(2):134-46. PubMed ID: 8322530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Affective, somatoform and anxiety disorders in Germany--initial results of an additional federal survey of "psychiatric disorders"].
    Wittchen HU; Müller N; Pfister H; Winter S; Schmidtkunz B
    Gesundheitswesen; 1999 Dec; 61 Spec No():S216-22. PubMed ID: 10726424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychotherapy and psychoanalysis in patient management: results of the Heidelberg Catamnesis Project].
    von Rad M; Senf W; Bräutigam W
    Psychother Psychosom Med Psychol; 1998; 48(3-4):88-100. PubMed ID: 9600004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liaison psychiatry in an internal medicine clinic. Study of a subgroup of patients with psychogenic reactions and neurotic disorders].
    Wolfersdorf M; Burg E; Herrlen-Pelzer S; Adler G
    Fortschr Med; 1994 Apr; 112(11):154-8. PubMed ID: 8200598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and pathophysiological aspects of psychogenic tremors.
    Deuschl G; Köster B; Lücking CH; Scheidt C
    Mov Disord; 1998 Mar; 13(2):294-302. PubMed ID: 9539344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The problem of psychogenic symptoms: is the psychiatric community in denial?
    Benbadis SR
    Epilepsy Behav; 2005 Feb; 6(1):9-14. PubMed ID: 15652726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.